Dawn Robertshaw

Dawn Robertshaw has a diverse work experience spanning several industries. Dawn currently works as the Director of Market Access at Melinta Therapeutics since September 2021. Prior to that, they served as the Key Account Manager for NY/NJ at Eagle Pharmaceuticals from March 2016 to September 2021. Dawn also worked at Hospira, a Pfizer company, as a Senior Anesthesia & Critical Care Account Executive from February 2009 to March 2016. Additionally, Dawn held the position of Account Executive at Hospira and Abbott, specializing in the Alternate Site sales, from 2004 to 2008 and from 2002 to 2004, respectively. Dawn started their career at Geisinger Health System as a Staff Nurse in the Pediatric Intensive Care unit from 1991 to 1994, and later as the Director of VITALine Home Infusion Pharmacy from 1997 to 2002. Throughout their career, Dawn has gained extensive experience in market access, key account management, and sales.

Dawn Robertshaw graduated from Widener University in 1988 with a Bachelor of Science in Nursing (BSN). There is no information available about their education prior to attending Widener University.